Tolerogenic Dendritic Cells: The Ins and Outs of Outcome
Authors:
- Bao-Guo XiaoBXBao-Guo Xiao
- Yu-Min HuangYHYu-Min Huang
- Hans LinkHLHans Link
- 1 September 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 29 (5) , 465-471
Abstract
Recent studies point to an important role for dendritic cells (DCs) in the induction of peripheral tolerance, revealing that the maturation and/or activation state of DCs might be a control point for the induction of peripheral tolerance. Recent progress in our understanding of the mechanisms mediating immune tolerance indicates them to be far more complex than hitherto anticipated. Factors deciding the outcome of vaccination with autologous DCs to prevent and treat diseases with an autoimmune background include maturation state of DCs, their administration route, long-term effects, antigen loading, and in vivo microenvironment. DC vaccination, although promising, is far from standardized. In this review, we discuss the ins and outs of DC-mediated immune tolerance and the need for careful experimental design to unequivocally prove the efficacy and reach the goal of optimized use of DCs in autoimmune diseases.Keywords
This publication has 49 references indexed in Scilit:
- Tolerization of dendritic cells by HLA‐GEuropean Journal of Immunology, 2005
- Antigen‐specific immunomodulation of collagen‐induced arthritis with tumor necrosis factor–stimulated dendritic cellsArthritis & Rheumatism, 2004
- Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosisJournal of Neuroimmunology, 2004
- Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cellsNeurobiology of Disease, 2004
- Pharmacological induction of tolerogenic dendritic cells and regulatory T cellsSeminars in Immunology, 2004
- Dendritic cells: emerging pharmacological targets of immunosuppressive drugsNature Reviews Immunology, 2004
- Pharmacologic, biologic, and genetic engineering approaches to potentiation of donorderived dendritic cell tolerogenicity1Transplantation, 2003
- Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survivalTransplantation, 2003
- Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?Trends in Immunology, 2002
- Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid TissueJournal of Experimental Medicine, 1998